Anal squamous cell carcinoma (SCC) is treated with the Nigro protocol. What is the standard chemoradiation regimen in this protocol?
- A Radiotherapy 45 Gy + concurrent cisplatin + 5-FU
- B Radiotherapy 60 Gy + concurrent capecitabine + oxaliplatin
- C Abdominoperineal resection followed by adjuvant chemoradiotherapy
- D Radiotherapy 45–54 Gy + concurrent 5-FU + mitomycin C ✓
Explanation
The Nigro protocol (now the ACT I/ACT II validated standard) for anal canal SCC consists of external beam radiotherapy (45–54 Gy) with concurrent 5-fluorouracil (continuous infusion during weeks 1 and 5) and mitomycin C (bolus on day 1 and day 29). This achieves complete response rates of ~80% and avoids abdominoperineal resection (APR) in the majority. Cisplatin was compared to mitomycin C in ACT II and did not improve outcomes; mitomycin C remains standard. APR is reserved for salvage after chemoradiation failure.
Reference: Bailey & Love's Short Practice of Surgery, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.